Literature DB >> 24493145

Importance of tumor size in soft tissue sarcomas: a proposal for a nomogram based on a score system to staging soft tissue sarcomas in the postoperative setting.

Rosa Angélica Salcedo Hernández1, Leonardo Saúl Lino-Silva, David Cantú de León, Ángel Herrera-Gómez, Héctor Martínez-Said, Abelardo Meneses-García.   

Abstract

In order to adequately stage patients with extremity soft tissue sarcomas (ESTS), it is mandatory to include all adverse prognostic factors and create an integral staging system. We were able to evaluate a nomogram based on a score (STSSS), to improve ESTS staging. We retrospectively evaluated 596 patients with ESTS in stages I-III, of the American Joint Committee on Cancer (AJCC), who had a complete resection. We analyzed the influence of clinicopathological factors on metastasis, recurrence, and disease-specific survival. The STSSS was based on histologic grade (HG), profundity, tumor size (TS), and surgical margins; we also compared STSSS versus AJCC systems in their ability to stage ESTS. The mean TS was 11.8 cm, with 50%>10 cm. Large TS and high HG were independent but adverse prognostic factors for metastasis. In addition, large TS, high grade, and R1 resection were independent adverse prognostic factors for decreased survival. There was a progressive decline in survival as TS increased, although AJCC staging did not correlate well between stages (IA vs. IB p=0.233, IA vs. IIA p=0.123, IA vs. IIB p=0.075, IB vs. IIA p=0.472, IB vs. IIB p=0.211). STSSS showed differences between these categories for 5-year survival (I vs. II p=0.003, II vs. III p=0.002, III vs. IV p<0.001). Surgical margins, HG, and TS are important determinants for metastases and survival. We also found a strong correlation between survival and prognosis with the use of STSSS in the immediate postoperative setting.

Entities:  

Mesh:

Year:  2014        PMID: 24493145     DOI: 10.1007/s12032-014-0873-z

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  35 in total

1.  Modified staging system for extremity soft tissue sarcomas.

Authors:  R C Ramanathan; R A'Hern; C Fisher; J M Thomas
Journal:  Ann Surg Oncol       Date:  1999 Jan-Feb       Impact factor: 5.344

2.  Prospective evaluation of quality of surgery in soft tissue sarcoma.

Authors:  E Stoeckle; H Gardet; J-M Coindre; G Kantor; F Bonichon; Y Milbéo; L Thomas; A Avril; B N Bui
Journal:  Eur J Surg Oncol       Date:  2006-06-21       Impact factor: 4.424

3.  Postoperative nomogram for 12-year sarcoma-specific death.

Authors:  Michael W Kattan; Denis H Y Leung; Murray F Brennan
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

4.  Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.

Authors:  Suzan E ten Heuvel; Harald J Hoekstra; Robert J van Ginkel; Esther Bastiaannet; Albert J H Suurmeijer
Journal:  Ann Surg Oncol       Date:  2006-10-22       Impact factor: 5.344

5.  Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma.

Authors:  Nabil Wasif; Robert M Tamurian; Scott Christensen; Ly Do; Steve R Martinez; Steven L Chen; Robert J Canter
Journal:  Ann Surg Oncol       Date:  2011-07-16       Impact factor: 5.344

6.  Protocol for the examination of specimens from patients with soft tissue tumors of intermediate malignant potential, malignant soft tissue tumors, and benign/locally aggressive and malignant bone tumors.

Authors:  Brian P Rubin; Christopher D M Fletcher; Carrie Inwards; Anthony G Montag; Terrance Peabody; Stephen J Qualman; Andrew E Rosenberg; Sharon Weiss; Thomas Krausz
Journal:  Arch Pathol Lab Med       Date:  2006-11       Impact factor: 5.534

7.  Upper-extremity sarcomas in the United States: analysis of the surveillance, epidemiology, and end results database, 1973-1998.

Authors:  Amy K Alderman; H Myra Kim; Sandra V Kotsis; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2003-05       Impact factor: 2.230

8.  The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases.

Authors:  J Costa; R A Wesley; E Glatstein; S A Rosenberg
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

9.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

10.  Malignant fibrous histiocytoma of the extremities and trunk: an institutional review.

Authors:  Matthias Peiper; David Zurakowski; Wolfram Trudo Knoefel; Jakob R Izbicki
Journal:  Surgery       Date:  2004-01       Impact factor: 3.982

View more
  3 in total

1.  Nomogram for predicting cancer-specific survival in undifferentiated pleomorphic sarcoma: A Surveillance, Epidemiology, and End Results -based study.

Authors:  Fengshuo Xu; Fanfan Zhao; Xiaojie Feng; Chengzhuo Li; Didi Han; Shuai Zheng; Yue Liu; Jun Lyu
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

2.  Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology.

Authors:  Melike Ozcelik; Mesut Seker; Emrah Eraslan; Sinan Koca; Dogan Yazilitas; Ozlem Ercelep; Ersin Ozaslan; Serap Kaya; Ilhan Hacibekiroglu; Serkan Menekse; Asude Aksoy; Burcu Yapar Taskoylu; Umut Varol; Erkan Arpaci; Aydin Ciltas; Berna Oksuzoglu; Nurullah Zengin; Mahmut Gumus; Mehmet Aliustaoglu
Journal:  Tumour Biol       Date:  2015-11-10

3.  GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas.

Authors:  Toshiaki Haraguchi; Hiroaki Miyoshi; Koji Hiraoka; Shintaro Yokoyama; Yukinao Ishibashi; Toshihiro Hashiguchi; Koutaro Matsuda; Tetsuya Hamada; Takahiro Okawa; Naoto Shiba; Koichi Ohshima
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.